| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 115,794 | 167,669 | 520,500 | 402,850 | | Cost of Revenue | 308,933 | 122,634 | 304,819 | 362,109 | | | Gross Profit | (193,139) | 45,035 | 215,681 | 40,741 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (173,718) | 49,991 | 104,143 | 42,064 | | Non Recurring | 15,064 | (9,656) | (5,408) |
-
| | Others | 6,303 | 3,744 | 6,066 | 6,043 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (24,348) | 956 | 110,880 | (7,366) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 14,268 | 1,305 | 8,006 | 4,022 | | Earnings Before Interest And Taxes | (26,520) | 2,261 | 118,886 | (3,344) | | Interest Expense | 2,623 | 4,683 | 5,517 | 5,019 | | Income Before Tax | (29,143) | (2,422) | 113,369 | (8,363) | | Income Tax Expense | (61,449) | (498) | 4,702 | (352) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 32,306 | (1,924) | 108,667 | (8,011) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 32,306 | (1,924) | 108,667 | (8,011) | | Preferred Stock And Other Adjustments | 423 | (423) |
-
|
-
| | | Net Income Applicable To Common Shares | $32,729 | ($2,347) | $108,667 | ($8,011) |
|
0.03% Nasdaq 
Income Statement
